Literature DB >> 10777603

Steady-state levels of histone acetylation in Saccharomyces cerevisiae.

J H Waterborg1.   

Abstract

The importance of control of the levels of histone acetylation for the control of gene expression in eukaryotic chromatin is being elucidated, and the yeast Saccharomyces cerevisiae has proven to be an important model system. The level of histone acetylation in yeast is the highest known. However, only acetylation of H4 has been quantified, and reports reveal loss of acetylation in histone preparations. A chaotropic guanidine-based method for histone isolation from intact wild-type cells or from a single-step nuclear preparation with butyrate preserves acetylation of all core histones. Histone H4 has an average of more than 2 acetylated lysines per molecule, distributed over 4 sites. Histones H2A, H3, and H2B have 0. 2, approximately 2, and >2 acetylated lysines per molecule, respectively, distributed across 2, 5, and 6 sites. Thus, yeast nucleosomes carry, on average, 13 acetylated lysines per octamer, i. e. just above the threshold of 10-12 deduced for transcriptionally activated chromatin of animals, plants, and algae. Following M(r) 100,000 ultrafiltration in 2.5% acetic acid, yeast histone H3 was purified to homogeneity by reversed-phase high pressure liquid chromatography. Other core histones were obtained at 80-95% purity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777603     DOI: 10.1074/jbc.275.17.13007

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Histone acetylation at promoters is differentially affected by specific activators and repressors.

Authors:  J Deckert; K Struhl
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Ssn6-Tup1 interacts with class I histone deacetylases required for repression.

Authors:  A D Watson; D G Edmondson; J R Bone; Y Mukai; Y Yu; W Du; D J Stillman; S Y Roth
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

3.  Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors.

Authors:  Yael Katan-Khaykovich; Kevin Struhl
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

4.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.

Authors:  Kazuhiro Ito; Sam Lim; Gaetano Caramori; Borja Cosio; K Fan Chung; Ian M Adcock; Peter J Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

5.  Targeted histone acetylation at the yeast CUP1 promoter requires the transcriptional activator, the TATA boxes, and the putative histone acetylase encoded by SPT10.

Authors:  Chang-Hui Shen; Benoit P Leblanc; Carolyn Neal; Ramin Akhavan; David J Clark
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

6.  Ordered nucleation and spreading of silenced chromatin in Saccharomyces cerevisiae.

Authors:  Laura N Rusché; Ann L Kirchmaier; Jasper Rine
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

Review 7.  Epigenome manipulation as a pathway to new natural product scaffolds and their congeners.

Authors:  Robert H Cichewicz
Journal:  Nat Prod Rep       Date:  2009-10-27       Impact factor: 13.423

8.  Radiosensitization of yeast cells by inhibition of histone h4 acetylation.

Authors:  Suisui Song; Kelly E McCann; J Martin Brown
Journal:  Radiat Res       Date:  2008-11       Impact factor: 2.841

9.  Functional connection between histone acetyltransferase Gcn5p and methyltransferase Hmt1p.

Authors:  Min-Hao Kuo; Xin-Jing Xu; Hella A Bolck; Dawei Guo
Journal:  Biochim Biophys Acta       Date:  2009-04-07

10.  The Schizosaccharomyces pombe JmjC-protein, Msc1, prevents H2A.Z localization in centromeric and subtelomeric chromatin domains.

Authors:  Luke Buchanan; Mickaël Durand-Dubief; Assen Roguev; Cagri Sakalar; Brian Wilhelm; Annelie Strålfors; Anna Shevchenko; Rein Aasland; Andrej Shevchenko; Karl Ekwall; A Francis Stewart
Journal:  PLoS Genet       Date:  2009-11-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.